** Shares of Cyclopharm CYC.AX rise 6.6% to A$1.525, their highest level since February 27
** Radiopharmaceutical co says its signed a 5-year agreement with USA Veterans Administration
** The five-year Federal Supply Schedule $(FSS)$ agreement works to expand co's medical radioactive technology Technegas’ adoption within the US federal healthcare system
** Stock set for second straight session of gains
** CYC up 4.7% YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.